Table of Contents
HMS-I2 1μM R06 exp286
Mechanism of Action
Technical Notes
Screen Summary
Screen Results
HMS-I2 1μM R06 exp286
Mechanism of Action
putative HDAC inhibitor from cell-based screen
Class / Subclass 1:
Uncharacterized Mechanism / Chemical Screen Hit
Technical Notes
Protein References
PubChem Name:
N-(1-Benzothiophen-2-yl)-4-[(2-chloro-6-fluorophenyl)methyl]piperazine-1-carboxamide
Synonyms:
N/A
CAS #:
690626-60-9
PubChem CID:
2811440
IUPAC:
N-(1-benzothiophen-2-yl)-4-[(2-chloro-6-fluorophenyl)methyl]piperazine-1-carboxamide
INCHI Name:
InChI=1S/C20H19ClFN3OS/c21-16-5-3-6-17(22)15(16)13-24-8-10-25(11-9-24)20(26)23-19-12-14-4-1-2-7-18(14)27-19/h1-7,12H,8-11,13H2,(H,23,26)
INCHI Key:
BPEPKMJSLJPOFO-UHFFFAOYSA-N
Molecular Weight:
403.9
Canonical SMILES:
C1CN(CCN1CC2=C(C=CC=C2Cl)F)C(=O)NC3=CC4=CC=CC=C4S3
Isomeric SMILES:
N/A
Molecular Formula:
C20H19ClFN3OS
Protein Supplier
Supplier Name:
MayBridge
Catalog #:
HTS 03843
Lot #:
N/A
Protein Characterization
HRMS (ESI-TOF) m/z:
(M+H)+ Calcd for C20H19ClFN3OS 404.09942; found 404.10247
Dose Response Curve
Dose response curve not available.
Screen Summary
Round
: 06
Dose
: 1µM
Days of incubation
: 8
Doublings
: 7.9
Numbers of reads
: 9120649
Screen Results
Sensitive/Resistant hits (FDR<0.05)
CRANKS
Score Plot
Top 30 Genes
Screen Similarity
Top 30 Sensitive GO terms
Top 30 Resistant GO terms
2/0
Scores
View
View
View
View
View
×
HMS-I2 1μM R06 exp286
×
Top 30 S/R Genes
Gene
CRANKS Score
FDR
PGGT1B
-3.10
<0.01
ATP6V0A1
-3.02
0.02
PRAMEF25
-2.81
0.64
PRAMEF26
-2.75
0.64
ADSL
-2.58
0.43
CFAP45
-2.56
0.62
DCAF5
-2.47
0.14
VMA21
-2.44
0.23
RPE
-2.42
0.23
ZNF736
-2.34
0.23
TMEM208
-2.23
0.26
MRPL33
-2.20
0.69
NANOS1
-2.10
0.49
EXOC8
-2.06
0.49
ALG9
-2.05
0.49
ELAC2
-2.05
0.49
ARL14EP
-2.01
0.49
UHRF1
-2.00
0.62
CEPT1
-1.95
0.55
PRRT2
-1.95
0.49
GPR173
-1.95
0.49
TRMT10A
-1.94
0.49
CDK18
-1.94
0.49
CIC
-1.94
0.49
PCM1
-1.93
0.64
VEZT
-1.93
0.49
RAB28
-1.92
0.49
CTC1
-1.92
0.64
PGK1
-1.91
0.61
PEX3
-1.91
0.49
ERP44
1.83
0.76
MTRNR2L9
1.85
0.85
HIST1H2BF
1.90
0.76
CDCA5
1.91
0.76
ARRB2
1.92
0.76
SLK
1.92
0.76
KCNK17
1.94
0.76
MSLN
1.94
0.76
GFI1
1.98
0.76
PSMA3
1.98
0.76
SSH2
2.00
0.76
SPC24
2.00
0.85
OTX1
2.01
0.76
NOM1
2.06
0.76
RPL30
2.06
0.85
INTS1
2.06
0.76
SLC16A4
2.09
0.76
SNRPF
2.12
0.85
PRMT5
2.24
0.85
RPL8
2.28
0.85
PSMB4
2.28
0.76
PLK1
2.30
0.76
INTS6
2.34
0.76
NUP160
2.45
0.76
USP17L17
2.60
0.76
NAPA
2.60
0.76
CLP1
2.65
0.76
DHX38
2.66
0.76
RPS11
2.78
0.76
NPIPA5
3.37
0.10
×
Correlated Screens
Screen
Correlation
Plot
Pyronaridine 1μM R06 exp295
0.057
View
Cisplatin 0.35μM R06 exp273
0.056
View
Geldanamycin 0.01μM R05 exp235
0.053
View
×
HMS-I2 1μM R06 exp286 vs Pyronaridine 1μM R06 exp295
×
Cisplatin 0.35μM R06 exp273 vs HMS-I2 1μM R06 exp286
×
Geldanamycin 0.01μM R05 exp235 vs HMS-I2 1μM R06 exp286
×
Top 30 sensitive GO terms
No GO term hits below threshold. (FDR <0.05)
×
Top 30 resistant GO terms
No GO term hits below threshold. (FDR <0.05)